Revenue: The sum of all revenue fields included for a company's operating activities.
Amphastar Pharmaceuticals, Inc. (AMPH) had Revenue of $183.90M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$183.90M |
$30.35M |
|
$90.43M |
|
$93.47M |
|
$144.17M |
|
$39.73M |
|
$-1.19M |
|
$38.54M |
|
$38.54M |
|
$30.35M |
|
$30.35M |
|
$30.35M |
|
$30.35M |
|
$39.73M |
|
$54.91M |
|
43.64M |
|
44.23M |
|
$0.69 |
|
$0.67 |
|
| Balance Sheet Financials | |
$630.95M |
|
$316.06M |
|
$1.11B |
|
$1.74B |
|
$263.20M |
|
$609.56M |
|
$712.40M |
|
$975.61M |
|
$768.16M |
|
$120.32M |
|
$768.16M |
|
42.53M |
|
| Cash Flow Statement Financials | |
$99.16M |
|
$28.14M |
|
$-73.74M |
|
$170.41M |
|
$223.85M |
|
$53.44M |
|
$16.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.40 |
|
-- |
|
-- |
|
0.44 |
|
0.80 |
|
50.83% |
|
21.60% |
|
21.60% |
|
-- |
|
20.96% |
|
16.50% |
|
$81.07M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.50 |
|
1.25 |
|
72.18 |
|
3.95% |
|
25.22% |
|
1.74% |
|
2.20% |
|
$18.06 |
|
$1.83 |
|
$2.24 |
|